Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation

Paul B. Rosenberg, Ank E. Vriesendorp, Mark H. Drazner, Daniel L. Dries, Patricia A. Kaiser, Linda S. Hynan, J. Michael Dimaio, Daniel Meyer, W. Steves Ring, Clyde W. Yancy

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint Dive into the research topics of 'Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences